Next Article in Journal
Molecular Signaling Mechanisms for the Antidepressant Effects of NLX-101, a Selective Cortical 5-HT1A Receptor Biased Agonist
Next Article in Special Issue
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib
Previous Article in Journal
Revolutionization in Cancer Therapeutics via Targeting Major Immune Checkpoints PD-1, PD-L1 and CTLA-4
Previous Article in Special Issue
The Use of Janus Kinase Inhibitors in Axial Spondyloarthritis: Current Insights
 
 
Review

Article Versions Notes

Pharmaceuticals 2022, 15(3), 336; https://doi.org/10.3390/ph15030336
Action Date Notes Link
article xml file uploaded 10 March 2022 10:51 CET Original file -
article xml uploaded. 10 March 2022 10:51 CET Update https://www.mdpi.com/1424-8247/15/3/336/xml
article pdf uploaded. 10 March 2022 10:51 CET Version of Record https://www.mdpi.com/1424-8247/15/3/336/pdf
article html file updated 10 March 2022 10:53 CET Original file -
article html file updated 1 August 2022 04:59 CEST Update https://www.mdpi.com/1424-8247/15/3/336/html
Back to TopTop